Intrathecal Rituximab in Treating Patients With Recurrent CNS Lymphoma

Clinical trial NCT00416923 · COMPLETED

Trial details

NCT number: NCT00416923
Sponsor: University of California, San Francisco
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Brain and Central Nervous System Tumors Lymphoma

Start date: 2002-08-01
Primary completion: 2005-11-01
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.